Distinct Molecular Processes In Placentae Involved In Two Major Subtypes of Preeclampsia
bioRxiv, ISSN: 2692-8205
2019
- 9Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures9
- Readers9
Article Description
Purpose: Patients with preeclampsia display a spectrum of onset time and severity of clinical presentation, yet the underlying molecular bases for the early-onset and late-onset clinical subtypes are not known. Methods: Since the root cause of PE is thought to be located in the placentae, RNA-seq has been performed on 65 high-quality placenta samples, including 33 from 30 patients and 32 from 30 control subjects, to search for molecular features. Results: Two functionally distinct sets of dysregulated genes have been identified in two major subtypes: metabolism-related genes, notably transporter genes, in early-onset severe preeclampsia (EOSPE) and immune-related genes in late-onset severe preeclampsia (LOSPE), while the late-onset mild preeclampsia (LOMPE) is not to be distinguished from normal controls. A small number of dysregulated transcription factors are found to drive the widespread gene dysregulation in both EOSPE and LOSPE. Conclusion: These results suggest that EOSPE and LOSPE have different molecular mechanisms, whereas the LOMPE may have no placenta-specific causal factors.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know